| abstract |
Pharmaceutical compositions comprising a 5-(mono- or di-substituted amino) alkyl ester 1,4-dihydropyridine derivative or a pharmaceutically acceptable salt thereof and 2-{2-[(1-ethoxycarbonyl)-3-phenylpropyl]amino}-1-oxopropyl-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinoline carboxylic acid or a lower alkyl acid ester, or the corresponding diacid, or the pharmaceutically acceptable salts thereof, and their use in treating diseases which are affected by calcium entry blockade asnd angiotensin converting enzyme inhibition. |